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This study was designed to evaluate the relation between 
severity of obstruction to left ventricular outflow and left 
ventricular ejection time in hypertrophic obstructive car- 
diomyopathy. With dual catheters across the left ventricu- 
lar outflow tract, the pressure gradient and corresponding 
left ventricular ejection time were measured in 10 patients 
as the pressure gradient was pharmacologically provoked 
or abolished, or both. The patients were studied during 
constant atriai pacing to avoid the potential errors intro- 
duced with heart rate correction equations. 
The pressure gradient was pharmacologically provoked 
or reduced over a range of 262 mm Hg per patient. In each 
patient the left ventricular ejection time varied directly with 
the pressure gradient (mean r = 0.97, range 0.92 to 1.00). 
The change in magnitude of the pressure gradient varied 
directly with the corresponding change in the measured 
ejection time (mean r = 0.98, range 0.97 to 1.00). 
When the data from all 10 patients were pooled with use 
Left ventricular ejection time is a physiologic variable of left 
ventricular systolic function that is influenced by heart rate. 
underlying left ventricular contractile state, forward stroke 
volume and presence of obstruction to left ventricular out- 
flow (I). In the absence of significant aortic regurgitation. 
prolongation of left ventricular ejection time is caused prin- 
cipally by obstruction to left ventricular outflow (11. In 
conditions with fixed obstruction to left ventricular outflow. 
such as valvular aortic stenosis. the ejection time (when 
corrected for stroke volume and heart rate) varies in direct 
relation to the severity of obstruction (2). Left ventricular 
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of Weissler’s heart rate correction equation, the relation 
between the corrected left ventricular ejection time and the 
pressure gradient was still significant and linear (r = 0.86), 
but less so than in individual patients. This difference was 
the result of marked interpatient variability in the slope of 
this linear relation reflecting interpatient differences in 
other important factors, such as underlying myocardial 
contractility and stroke volume, that influence left ventric- 
ular ejection time. 
This study demonstrates a clear, direct and highly 
significant relation between the magnitude of the pressure 
gradient and the left ventricular ejection time in hypertro- 
phic obstructive cardiomyopathy. These findings suggest a 
causal relation between the pressure gradient and ejection 
time and support the concept that the pressure gradient in 
this condition represents a true mechanical impediment to 
left ventricular outflow. 
(J Am Co11 Cardiol1989;13:1275-9) 
ejection time has also been reported (3) to be prolonged and 
to vary directly with the degree of dynamic obstruction in 
patients with obstructive hypertrophic cardiomyopathy. 
where the obstruction differs from that of valvular aortic 
stenosis in timing of onset. duration and contour. In that 
study. the ejection times of patients with different pressure 
gradients and different heart rates were compared by divid- 
ing the measured ejection time by the square root of the 
preceding RR interval. a modification of Bazett’s heart rate 
correction equation. The results were questioned, however, 
because of a potential error introduced when the left ven- 
tricular ejection time is corrected for heart rate with this 
method (3) or with other methods utilizing linear regression 
equations (I 1. Furthermore, an alternative mechanism has 
been proposed for the prolongation of left ventricular ejec- 
tion time in these patients, ascribing it to impaired relaxation 
of the hypertrophied left ventricle rather 
impediment to left ventricular outflow (4). 
To further investigate this relation. we 
than to a true 
performed this 
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study to determine the direct, independent effect of the 
pressure gradient on left ventricular ejection time in patients 
with obstructive hypertrophic cardiomyopathy. 
Methods 
Study patients. The study group consisted of 10 patients 
with obstructive hypertrophic cardiomyopathy undergoing 
cardiac catheterization for clinical purposes. The diagnosis 
of hypertrophic cardiomyopathy and the presence of a 
pressure gradient at rest or with provocation, were estab- 
lished by echocardiography (5,6) before catheterization in all 
patients. In no patient was there clinical or echocardio- 
graphic evidence of valvular aortic stenosis. Cardiac medi- 
cations (beta-adrenergic blockers, calcium-channel blockers 
and disopyramide) were discontinued 48 to 72 h before the 
study in all patients. 
Pressure gradient recording. Simultaneous pressures 
across the left ventricular outflow tract were measured with 
two fluid-filled catheters, a transseptal catheter placed in the 
left ventricular inflow tract and a retrograde aortic catheter 
placed in the ascending aorta. Catheter entrapment was 
ruled out by previously established criteria (7). Briefly, these 
included verification that the catheter tip was freely mobile 
in a blood-filled area of the left ventricle, withdrawing blood 
from the catheter throughout the cardiac cycle, and verifi- 
cation of the normal timing of left ventricular systolic 
pressure decline. The pressure tracings were simultaneously 
recorded at a paper speed of 100 mm/s. 
Pressure gradient manipulation. The pressure gradient in 
each patient was manipulated pharmacologically to obtain as 
wide a range of pressure gradients per patient as possible. 
Isoproterenol(2 to 8 pg, intravenously) and amyl nitrate (by 
inhalation) were used to provoke the pressure gradient; 
disopyramide (50 to I50 mg, intravenously) and phenyleph- 
rine (0.2 to 1 .O mg, intravenously) were used to decrease it. 
Atrial pacing protocol. In each patient atrial pacing was 
performed at a constant rate throughout the study. One 
patient had a previously placed permanent atrioventricular 
(AV) sequential pacemaker for management of complete 
heart block. The other nine patients had normal sinus 
rhythm, and a temporary atria1 pacing catheter was used 
during the study. The pacing rate exceeded any drug- 
induced changes in the intrinsic sinus rates. 
Measurements. The pressure gradient across the left ven- 
tricular outflow tract per beat was defined and measured as 
the difference between the peak left ventricular and peak 
aortic systolic pressures. Left ventricular ejection time per 
beat was measured, according to the standard definition and 
method, as the interval from the onset of the upstroke to the 
trough of the dicrotic notch of the ascending aortic pressure 
tracing. This measurement, made from the pressure tracings 
recorded at a paper speed of 100 mm/s, has been demon- 
strated and validated as a highly accurate and precise 
estimate of the left ventricular ejection time (1,8). 
Each data point (pressure gradient and corresponding left 
ventricular ejection time) was obtained with the pressure 
gradient held relatively constant over several beats, and 
consisted of the average ejection time and pressure gradient 
of 23 consecutive beats with a similar pressure gradient. 
Only normal sinus beats were measured; postextrasystolic 
beats were excluded from analysis. For each data point (3 to 
5 consecutive beats) the mean beat to beat variability of the 
left ventricular ejection time was 6 ms (range 0 to 16). 
In addition to the pressure gradient-left ventricular ejec- 
tion time relation in the individual patients, the corrected left 
ventricular ejection time (LVETc) was used to pool the data 
of all 10 patients. Weissler’s linear regression equation (9) 
was used as follows: for men, LVETc = LVET t (HR x 
1.7) and for women LVETc = LVET t (HR x 1.6), where 
HR = heart rate. 
Statistical analysis. Correlation between the pressure gra- 
dient and left ventricular ejection time in individual patients 
was assessed by linear regression analysis using the least 
squares method. The same method was used to correlate the 
pooled data from all 10 patients. 
Results 
Atrial pacing (Table 1). The atria1 pacing rate ranged 
from 68 to 120 beatsimin. In each case the atria1 rate was 
kept constant throughout the study, and in no case did the 
intrinsic sinus rate exceed the atria1 pacing rate. No compli- 
cations related to atria1 pacing were encountered and no 
significant change in the baseline gradient was observed with 
atria1 pacing. 
Pressure gradient-left ventricular ejection time relation: 
individual patients (Table 1). Baseline pressure gradient in 
the 10 patients ranged from 10 to 137 mm Hg (mean 76). With 
pharmacologic manipulations the pressure gradient ranged 
from 0 to 142 mm Hg, the measured left ventricular ejection 
time from 203 to 388 ms, and the corrected ejection time 
from 333 to 516 ms. 
The baseline (at rest) pressure gradient in each case was 
pharmacologically increased or decreased, or both, so that 
the difference between the maximal and minimal obtainable 
pressure gradients was ~62 mm Hg (range 62 to 121). The 
corresponding difference between the maximal and minimal 
measured ejection time in each patient ranged from 43 to 183 
ms. 
Three or more data points (mean 4.4) were obtained in 
each of the 10 patients. In every patient the left ventricular 
ejection time varied directly with the pressure gradient (Fig. 
l), (mean correlation r = 0.97; range 0.92 to 1.0). Although 
this relation was linear in each case, the slope of this relation 
varied widely, by as much as a factor of 4, from case to case 
(Fig. 2). 
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Table 1. Summary of the Interventions Used to Manipulate the Pressure Gradient. the Corresponding Left Ventricular Ejection Time and 
the Correlation and Slope of Their Relation in All 10 Patients 
Pre\wre 
Heart Rate GWkflt Correlation (r) 
Patient (heat$/min I Intervention imm Hg) LVE’I cm\) and Slope (k) 
I I10 I) il 231) r = 0.9x 
I> ;I 1.53 ) = 0.70x t 3YY 
D II! 170 
B I,l? 1-96 
! I IO r = 0.995 
) = 0.59x + 395 
4 
100 
IO0 
6X 
x0 
D 10 219 
D lfl 119 
B ‘76 1.55 
B Y! 262 
0 
!O 
4x 
57 
I,6 
X? 
‘J-1 
121 
227 
7% 
237 
211 
246 
260 
1x0 
2x5 
B IO 100 
A i1 3.50 
I 71 345 
D x 140 
1) Y 262 
D II 763 
B I’3 340 
I’ = 0.9x 
\ = O..c?X t 3x4 
I’ = 0.95 
v = 0.61X t 383 
r = O.Y? 
\ = 0.95x + 399 
r = 0.9x 
\ = 0.88X t 371 
1) 1-l 2.5: r 7 0.9: 
D fr5 2x7 > 0.7ix t 392 
D ;‘I 2x3 
B I15 330 
I’ 
U 
B 
r y 1.0 
\ = 2.22x t 335 
B II 2113 I = 0.94 
I ;I 250 ! = I.I!X t 354 
I 73 777 
D x 261 I_ = 0.975 
II I? 260 ! = 1.06X t 376 
D ?I !6(1 
D 4x 2x5 
B XX 340 
A = amyl nitrite inhalation: B := baseline: D = ditopyramide (CO to I50 mg. intrakenourlyl: I = iioproterenol (2 to 8 pg. intravenously): LVET = left 
ventricular qjection time: P = phenqlephrine (0.2 to 1.0 mg. intravenously). 
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Figure 1. Left ventricular ejection time (LVET) is plotted against 
the pressure gradient in a patient with hypertrophic cardiomyopa- 
thy. The pressure gradient is manipulated pharmacologically from 
baseline (B) with disopyramide (D) and isoproterenol (I). The heart 
rate is held constant at 110 beatslmin by atrial pacing. There is a 
direct relation (r = 0.99) between the ejection time and the pressure 
Figure 3. Change in left ventricular ejection time (A LVET) is 
plotted against the change (A) in the pressure gradient in the same 
patient as in Figure I. The heart rate is held constant at 110 beats/ 
min. There is a direct linear relation (r = 0.99) between the 
magnitude of change in the pressure gradient and the degree of 
prolongation in ejection time. 
gradient 
In seven patients, sufficient (>3) data points were ac- 
quired for correlation of the magnitude change in the pres- 
sure gradient with the corresponding change in the ejection 
time. In each case the change in left ventricular ejection time 
was directly related to the change in the pressure gradient 
(Fig. 3) with a mean correlation of r = 0.98 (range 0.97 to 
1.0). 
Pressure gradient-left ventricular ejection time relation: 
pooled patients. To define the pressure gradient-ejection 
time relation for the entire group (as done in previous 
studies), the data from all 10 patients were pooled together, 
using Weissler’s heart rate correction equation (9). The left 
ventricular ejection time again varied directly with the 
magnitude of the pressure gradient. However, because of the 
variability of the slopes of this relation in the individual 
patients, the correlation for the group as a whole was less 
than it was in the individual cases, with r = 0.86 (Fig. 4). 
Likewise, when the change in ejection time was correlated 
Figure 2. Left ventricular ejection time (LVET) is plotted against 
the pressure gradient in two patients (A and B) with hypertrophic 
cardiomyopathy. Patient B is the same patient as in Figure 1. The 
pressure gradient is manipulated pharmacologically from baseline 
(B) with disopyramide (D), isoproterenol (I) and phenylepherine (P). 
There is a linear relation between the ejection time and the pressure 
gradient in each patient, but the slopes of these relations are 
markedly different as demonstrated. 
with the change in pressure gradient for all 10 patients, the 
correlation for the group was again less than in the individual 
cases, with r = 0.63 (Fig. 5). 
Discussion 
Pressure gradient-left ventricular ejection time relation in 
hypertrophic cardiomyopathy. This study demonstrates a 
clear and direct, highly significant relation between the 
magnitude of the pressure gradient across the left ventricular 
outflow tract and the duration of left ventricular ejection 
time in patients with obstructive hypertrophic cardiomyop- 
athy. This relation is independent of heart rate, and is most 
pronounced when measured in individual patients over a 
wide range of pressure gradients. In addition, this study 
demonstrates a direct, highly significant relation between the 
magnitude of change in the pressure gradient and the degree 
of prolongation of ejection time. These two observations 
support strongly the concept that the changes in left ventric- 
ular ejection time and the pressure gradient are causally 
related. 
Of importance is that, although these relations are linear 
in the individual cases, the slopes of these relations vary 
Figure 4. Corrected left ventricular ejection time (LVETc) in all 10 
patients studied is plotted against the pressure gradient. There is a 
direct relation (r = 0.86) between both variables. 
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Figure 5. Change in corrected left ventricular ejection time 
(LVETc) is plotted against the change CA) in the pressure gradient 
for all IO patients studied. There is a direct linear relation (r = 0.63) 
between the magnitude change in both variables. 
widely from patient to patient. This may be due to differ- 
ences in left ventricular loading conditions, differences in left 
ventricular contractility. differences in the pharmacologic 
means by which the pressure gradient was manipulated in 
each patient, or a combination thereof. Specific analysis of 
the medications used in this study demonstrated no consis- 
tent effect on the slope of the pressure gradient-ejection time 
relation. In fact, the slopes remained linear even in patients 
given two or three different medications. This argues against 
an independent effect of the medications alone on the slope 
of the relation. Regardless of the underlying mechanism, this 
finding explains the somewhat weaker correlations found in 
this study when the data of all IO patients were pooled 
together, using the corrected left ventricular ejection time as 
described by Weissler et al. (9). 
The medications used in this study may have affected the 
duration of left ventricular ejection time independently of 
their actions on the pressure gradient. lsoproterenol and 
amyl nitrite normally reduce the left ventricular ejection 
time. In this study. however, they were used to provoke the 
pressure gradient. and were always associated with an 
increase. rather than the expected decrease. in the ejection 
time. This finding IS similar to those of previously published 
reports (IO) and serves to further demonstrate the positive 
relation between the pressure gradient and left ventricular 
ejection time in this condition. Disopyramide is normally 
associated with a reduction of <6.4% in left ventricular 
ejection (I 1). In this study it was used to reduce the pressure 
gradient, which resulted in a much greater decrease in 
ejection time than would otherwise be expected. 
Mechanism of prolongation of left ventricular ejection time 
in hypertrophic cardiomyopathy. This study did not specifi- 
cally assess myocardial relaxation, and therefore does not 
completely refute or discount the argument that prolongation 
of left ventricular ejection time in these patients is related to 
impaired myocardlal relaxation. However, the demonstra- 
tion in this study that isoproterenol-which is expected to 
improve the rate of relaxation-resulted in further prolonga- 
tion of left ventricular ejection time argues strongly against 
this possibility. It should also be noted that prolongation of 
left ventricular ejection time has never been demonstrated in 
hypertrophic cardiomyopathy without the presence of a 
pressure gradient, and that impaired myocardial relaxation 
in these patients has been related principally to the extent of 
hypertrophy rather than to the presence or absence of a 
pressure gradient (12.13). In this context, our findings of the 
direct, linear relation between left ventricular ejection time 
and the pressure gradient, as well as between the change in 
ejection time and the change in the pressure gradient are 
suggestive that the two are causally related. 
These findings strongly support the concept that the 
pressure gradient in this condition is associated with true 
impediment to left ventricular outflow, as assessed by its 
effects on the time course of ejection. 
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